← Open Payments lookup

ZHENG CHEN: Open Payments

NPI 1669878807 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,172 in 177 payments from 21 companies in 2025. Trend: 2023 $805 · 2024 $1,705 · 2025 $4,172

Food & beverage: $4,172
CompanyPaymentsAmount
Janssen Biotech, Inc.25$785
ABBVIE INC.19$579
Takeda Pharmaceuticals U.S.A., Inc.24$500
PFIZER INC.30$488
Madrigal Pharmaceuticals15$437
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$257
Ardelyx, Inc.8$252
Gilead Sciences, Inc.3$145
Celltrion USA Inc.14$141
GENZYME CORPORATION4$93

Products named: TREMFYA, REZDIFFRA, ENTYVIO, VELSIPITY, XIFAXAN, IBSRELA, CREON, XELJANZ.

Industry payments across MD — which companies pay providers there.